Home » Topics » BioWorld Science

BioWorld Science
RSS

Alliance between Bicycle Therapeutics and ThromboGenics sees milestone and expansion

May 25, 2018

PACIFIC trial of Imfinzi in NSCLC meets second primary endpoint of overall survival

May 25, 2018

Phase III iLLUMINATE trial of Imbruvica plus Gazyva in first-line CLL/SLL meets primary endpoint

May 25, 2018

Portola Pharmaceuticals receives milestone payment following Andexxa approval

May 25, 2018

Celon Pharma evaluates 5-HT6 receptor antagonist PZ-KKN-94 in vitro and in vivo

May 25, 2018

Recro receives complete response letter from the FDA for intravenous meloxicam

May 25, 2018

Updated results strengthen previously reported 2-year survival rate of TG-01

May 25, 2018

Recombinant human pentraxin 2 slows decline in lung function in IPF patients

May 25, 2018

CEPI and IAVI partner to develop Lassa fever vaccine

May 25, 2018

Novo Nordisk licenses EPGN-696 from Epigen

May 25, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...